Hospital acquired and ventilator associated pneumonia

view the recording here

Thank you for taking the time to view this webinar, we hope you find it informative.

RCPath CPD accredited

Co-presenters: Professor Tony Whitehouse, Dr Tim Felton, Dr Andrew Walden and Dr Andrew Conway-Morris

– – – – –

If you require a certificate of attendance, details of how to obtain will appear at the end of the webinar.

Please note that once you have completed your details on the form, the certificate will be generated so please be ready to download your certificate immediately. We would like to inform delegates that each time a certificate is generated, we will be notified with details.

If you have any problems creating or downloading your certificate please contact Esme Carruthers at ecarruthers@bsac.org.uk


e-Learning course:

Hospital Acquired and Ventilator Associated Pneumonia

The aim of this course is to provide an overview of some of the commonly identified infection issues that occur in patients with Hospital Acquired and Ventilator Associated Pneumonia. This course will provide an overview of where the field of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) treatment is now, the definitions of lower respiratory tract infections and pneumonia, and the potential harms of antimicrobials. You will also be able to follow an illustrative case study relating to day-to-day practice.

This will open the log in page in your default browser, all you will need to do is input an email and make a password, then you will be automatically redirected to the course.

If you have any issues with accessing the course, please contact navin@BSAC.org.uk.

Activate course link
By ticking this box and accessing the course you confirm you’re happy for BSAC to send you details of other content we think you’ll like. We’ll never share your details with a third party and you can unsubscribe at any time.

Speakers

Professor Tony Whitehouse, Consultant Critical Care & Anaesthesia Honorary Professor, University of Birmingham

Tony Whitehouse is Honorary Professor of Intensive Care Medicine in the Institute of Inflammation and Ageing and a Critical Care Consultant at the Queen Elizabeth Hospital in Birmingham.

He is lead for Clinical Critical Care Research in the UK’s largest ICU at the QE and Chief Investigator for the NIHR-funded STRESS-L study. His interests are antibiotic stewardship in Critical Illness and management of infection in resistant organisms. Some of his other studies are to investigate the use of large datasets for outcomes in critical care and a study of the microbiome in critically ill patients.

Dr Andrew Walden, Consultant in Acute Medicine & Intensive Care Medicine, Royal Berkshire NHS Foundation Trust

Dr Andrew Walden has been an NHS consultant in Acute Medicine and Intensive Care Medicine for over 10 years. He has widespread experience of Point of Care diagnostics having developed national competencies for Point of Care Ultrasound and publishing widely around the topic in this country and in resource poor settings, worldwide. He is a strong advocate of precision diagnostics in acutely unwell patients, as he believes that this leads to better triage, management and outcomes. Within the Royal Berkshire hospital he has led of the implementation of Point and Care and near patient testing PCR based technologies for early microbiological diagnosis in meningo-encephalitis, pneumonia and bacteraemia. This has led to improved antimicrobial stewardship and source control of sepsis with the Royal Berkshire hospital being the 4th lowest user of carbapenem antibiotics in the country

Dr Dan Wootton, NIHR Advanced Fellow, Senior Clinical Lecturer and Honorary Consultant Respiratory Physician, University of Liverpool

I work on respiratory tract infections.
In particular, the syndromes – community and hospital acquired pneumonia (CAP and HAP).
I focus on these diseases because they are common, severe and investment in the understanding and management of these conditions has been poor.

CAP is the commonest infection related reason for being admitted to hospital in the UK.
HAP is the most common hospital associated infection in UK.
CAP has a higher in-patient mortality than either stroke or heart attack.
HAP is even more severe with an in-patient mortality of 30% or more.

Dr Tim Felton, Clinical Senior Lecturer, University of Manchester

Tim Felton is a Consultant in Intensive Care and Respiratory Medicine at Manchester University NHS Foundation Trust and Senior Lecture in the Division of Infection, Immunity and Respiratory Medicine at the University of Manchester. He qualified in medicine in 1999 at the University of Nottingham. Dr Felton undertook his training in Respiratory and Intensive Care Medicine in the North West of England and in Sydney, Australia. He completed an MRC Clinical Research Training Fellowship and was awarded his PhD in anti-infective pharmacology by The University of Manchester in 2014. His research interests are in the diagnosis and optimal treatment of sepsis and other infections in critically ill patients. He has particular expertise related to optimising antimicrobial drug regimens to suppress emergence of anti-microbial resistance. Dr Felton has received £2.5M of external grant funding over the last 5 years. He is involved in a number of academic and commercial clinical trials in critically ill patients with severe infections.

Dr Andrew Conway Morris, MRC Clinician Scientist, University of Cambridge, Honorary Consultant in Intensive Care Medicine, JVF Intensive Care Unit, Addenbrooke’s Hospital, Cambridge & Chair, European Society of Intensive Care Medicine Infection Section

Dr Conway Morris is a critical care consultant and MRC Clinician Scientist based at the University of Cambridge. He trained at the Universities of Glasgow and Edinburgh, undertaking a PhD in Edinburgh focused on immune failure in critical illness and nosocomial infection. His work in this field has led to the development of several diagnostics for pneumonia, focussing on both host-response and pathogen detection. He is the current chair of the European Society of Intensive Care Medicine’s Infection Section, and is involved in a range of ICU-focussed antimicrobial stewardship projects.